OpenVSafe by OpenVAERS
Search V-safe

2GV-13117-24818

1 vaccination 7 coded responses 9 check-ins 7 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
405 / KY
Registered
2021-02-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-03
    Registered in v-safe
  2. 2021-02-03
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-03
    Survey response — day 0, dose 1
    MedDRA: Pruritus — Feeling: Good · Site: Pain
    Free text: Some itching on body. No one specific area. No rash identified
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus — Feeling: Poor · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Itching. Lots of generalized itching all over my body. No rash. No redness. Maybe one hive?
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus — Feeling: Fair · Site: Itching · Muscle or body aches, Fatigue or tiredness, Diarrhea
    Free text: Generalized itching. Mainly on upper body & torso. No evident rash noticed. No hives
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-06
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus — Feeling: Fair · Site: Itching · Rash, not including the immediate area around the injection site
    Free text: Generalized itching continues but lessens each day. Primarily on upper body and torso.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-07
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus, Rash, Rash erythematous — Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection site
    Free text: Itching continues on upper body & now seeing a flat red rash on arms and upper chest. Mitigating itching with oatmeal body wash & benadryl cream.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: Adverse reaction — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Same as previously reported
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-10
    Health check-in — day 7, dose 1
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  10. 2021-02-17
    Survey response — day 14, dose 1
    MedDRA: Rash, Rash maculo-papular — Feeling: Good
    Free text: Maculopapular rash continues to be present on chest. All other rash had resolved
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-08-04
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-03Pfizer-BioNTech

Free text

Release 3 — day 0, dose 1

2021-02-03

Systemic reaction (other): Some itching on body. No one specific area. No rash identified

Release 3 — days 1–6 daily, dose 1

2021-02-04

Systemic reaction (other): Itching. Lots of generalized itching all over my body. No rash. No redness. Maybe one hive?

2021-02-05

Systemic reaction (other): Generalized itching. Mainly on upper body & torso. No evident rash noticed. No hives

2021-02-06

Systemic reaction (other): Generalized itching continues but lessens each day. Primarily on upper body and torso.

2021-02-07

Systemic reaction (other): Itching continues on upper body & now seeing a flat red rash on arms and upper chest. Mitigating itching with oatmeal body wash & benadryl cream.

2021-02-08

Systemic reaction (other): Same as previously reported

Release 4 — day 14, dose 1

2021-02-17

Symptoms: Maculopapular rash continues to be present on chest. All other rash had resolved

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRash ✓ ✓ ✓
SDRash maculo-papular ✓ ✓ ✓
SROAdverse reaction ✓ ✓ ✓
SROPruritus ✓ ✓ ✓
SRORash ✓ ✓ ✓
SRORash erythematous ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release